EP
ITCI
Eversept Partners’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-124,491
| Closed | -$9.11M | – | 82 |
|
|
2024
Q3 | $9.11M | Buy |
+124,491
| New | +$9.11M | 0.62% | 29 |
|
|
2023
Q2 | – | Sell |
-218,726
| Closed | -$11.8M | – | 76 |
|
|
2023
Q1 | $11.8M | Buy |
+218,726
| New | +$11.8M | 0.83% | 22 |
|
|
2022
Q1 | – | Sell |
-231,787
| Closed | -$12.1M | – | 101 |
|
|
2021
Q4 | $12.1M | Buy |
231,787
+1,043
| +0.5% | +$54.6K | 0.78% | 27 |
|
|
2021
Q3 | $8.6M | Buy |
230,744
+113,282
| +96% | +$4.22M | 0.6% | 38 |
|
|
2021
Q2 | $4.79M | Sell |
117,462
-183,125
| -61% | -$7.48M | 0.32% | 38 |
|
|
2021
Q1 | $10.2M | Sell |
300,587
-55,648
| -16% | -$1.89M | 0.77% | 32 |
|
|
2020
Q4 | $11.3M | Buy |
356,235
+179,477
| +102% | +$5.71M | 1.33% | 21 |
|
|
2020
Q3 | $4.54M | Buy |
+176,758
| New | +$4.54M | 1.01% | 25 |
|